Alopecia Areata Trial, Recruiting NCT07041489 Sponsor: The Center for Clinical and Cosmetic Research Condition: Alopecia Areata
Back to Alopecia Areata

Alopecia Areata Trial, Recruiting

NCT07041489
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman between 28 and 65 years old who feels your hair has been consistently getting thinner
  • A doctor has assessed your hair loss as mild to moderate (using a standard hair loss scale called the Ludwig Scale, levels I or II)
  • You have any skin tone (all skin types are welcome)
  • You are willing to keep your current diet, medications, exercise habits, hair washing routine, and hair coloring habits the same for the whole study
  • You are able and willing to attend regular study visits and use the study product as instructed
  • You are willing to sign a consent form, including allowing photos to be taken as part of the study
  • If you could become pregnant, you have a negative pregnancy test at the start and agree to use a reliable form of birth control throughout the study (such as the pill, implant, injection, patch, IUD, condom, diaphragm, abstinence, or a partner who has had a vasectomy)

Who may not be able to join:

  • You are pregnant, breastfeeding, or planning to become pregnant
  • You have changed your hormone therapy (such as HRT or hormonal medications) in the last 6 months or plan to during the study
  • You have used medical hair loss treatments such as Minoxidil, Dutasteride, Finasteride, or laser/light therapy for the scalp in the past 3 months or plan to during the study
  • You have had micro-needling, PRP injections, or similar scalp treatments in the past 6 months or plan to during the study
  • You have taken GLP-1 medications (such as Semaglutide/Ozempic) in the past 6 months or plan to during the study
  • You have an uncontrolled health condition (such as a thyroid condition or anemia) that could affect the study results
  • You have a known allergy or sensitivity to any ingredient in the study product
  • The study doctor believes you may be unable or unwilling to follow the study rules and complete the study
  • You have any other health condition or finding that the study doctor believes would make it unsafe or unsuitable for you to participate (confirm with trial site)
  • You have taken part in a trial involving an experimental drug, medical device, or biologic treatment within the past 12 weeks

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Danielle Leavitt, Restore Biologics Holdings, Inc. dba Xtressé

Phone: 305-933-6716

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Center for Clinical and Cosmetic Research
Registry
ClinicalTrials.gov
Start date
20 May 2025
Est. completion
20 March 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Increase in hair density (hairs per cm²) measured as the within-subject change from baseline to Month 3, assessed via Canfield HairMetrix® phototrichogram analyses.; Increase in hair density (hairs per cm²) Measured as the within-subject change from baseline to Month 9, assessed via Canfield HairMetrix® phototrichogram analyses.; Participant self-assessment of hair growth and satisfaction, collected via validated questionnaires.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov